{"id":999,"date":"2020-12-07T10:00:00","date_gmt":"2020-07-27T11:03:00","guid":{"rendered":"https:\/\/eu.bd.com\/iv-news\/?p=999"},"modified":"2020-12-08T07:46:25","modified_gmt":"2020-12-08T07:46:25","slug":"picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer","status":"publish","type":"post","link":"https:\/\/eu.bd.com\/iv-news\/fr\/evenements-et-formation\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\/","title":{"rendered":"PICC ou CCI, quel dispositif pour les patients atteints de cancer\u00a0?"},"content":{"rendered":"<p class=\"p1\">Le choix du dispositif d\u2019abord vasculaire (DAV) est essentiel en oncologie. Les professionnels de l\u2019oncologie doivent tenir compte de plusieurs facteurs. Diff\u00e9rentes options impliquent diff\u00e9rents avantages et risques de complications. Le professeur Baudolino Mussa de l\u2019universit\u00e9 de Turin a abord\u00e9 ces sujets lors d\u2019une conf\u00e9rence intitul\u00e9e \u00ab\u00a0The appropriate choice of device in the oncology patient: review of the literature and survey 2019\u00a0\u00bb au Multidisciplinary Advanced Course on Vascular Access (MACOVA) 2020 \u00e0 Edimbourg, au Royaume-Uni.<\/p>\n<p class=\"p1\"><b>Des CCI aux PICC<\/b><\/p>\n<p class=\"p1\">Les m\u00e9dicaments anti-canc\u00e9reux et les abords veineux centraux ont \u00e9t\u00e9 mis au point apr\u00e8s la fin de la Seconde Guerre mondiale<span class=\"s1\"><sup>1<\/sup><\/span>. La chambre \u00e0 cath\u00e9ter implantable (CCI) a \u00e9t\u00e9 invent\u00e9e vers 1970<span class=\"s1\"><sup>1<\/sup><\/span>. Les cath\u00e9ters centraux \u00e0 insertion p\u00e9riph\u00e9rique (PICC) sont disponibles depuis les ann\u00e9es\u00a01970, mais leur utilisation a consid\u00e9rablement augment\u00e9 depuis 2000 pour plusieurs raisons.<span class=\"s1\"><sup>2<\/sup><\/span>\u00a0:<\/p>\n<ul class=\"ul1\">\n<li class=\"li1\">Facilit\u00e9 de pose<\/li>\n<li class=\"li1\">Le guidage par ultrasons assure une bonne correcte<\/li>\n<li class=\"li1\">Co\u00fbt d\u2019insertion inf\u00e9rieur \u00e0 celui des autres DAV<\/li>\n<li class=\"li1\">Facilit\u00e9 de retrait<\/li>\n<\/ul>\n<p class=\"p1\"><b>Mais sont-ils s\u00e9curitaires\u00a0?<\/b><\/p>\n<p class=\"p1\">Le professeur Mussa a ensuite pr\u00e9sent\u00e9 les donn\u00e9es d\u2019une \u00e9tude de Chopra et al comparant les taux de complication entre les PICC et les autres DAV<span class=\"s1\"><sup>3<\/sup><\/span>. Apr\u00e8s avoir effectu\u00e9 une \u00e9tude syst\u00e9matique, M. Chopra a constat\u00e9 que les PICC pos\u00e9s pour les patients hospitalis\u00e9s \u00e9taient deux fois plus susceptibles de provoquer des septic\u00e9mies que ceux pos\u00e9s en ambulatoire <span class=\"s1\"><sup>3<\/sup><\/span>. La thrombose est plus fr\u00e9quente chez les patients atteints d\u2019un cancer que chez ceux qui n\u2019en ont pas<span class=\"s1\"><sup>3<\/sup><\/span>. Dans une m\u00e9ta-analyse men\u00e9e par Saber et al, il s\u2019est r\u00e9v\u00e9l\u00e9 que les taux de thrombose \u00e9taient plus \u00e9lev\u00e9s chez les patients avec un PICC que chez ceux ayant des CCI<span class=\"s1\"><sup>4<\/sup><\/span>. Toutefois, M. Chopra a laiss\u00e9 entendre que les taux de thrombose pour les PICCpeuvent varier en fonction des techniques utilis\u00e9es pour les placer<span class=\"s1\"><sup>3<\/sup><\/span>.<\/p>\n<p class=\"p1\">Le professeur Mussa et ses coll\u00e8gues ont r\u00e9alis\u00e9 une \u00e9tude prospective sur les PICC chez les canc\u00e9reux trait\u00e9s en h\u00f4pital de jour <span class=\"s1\"><sup>2<\/sup><\/span>. Ils ont constat\u00e9 que les taux d\u2019infections sanguines li\u00e9es aux cath\u00e9ters (CRBSI), de complications m\u00e9caniques et de thromboses \u00e9taient faibles chez les patients ayant un PICC<span class=\"s1\"><sup>2<\/sup><\/span>. Leur principale conclusion est que lorsque les PICC sont bien entretenus \u00e0 l\u2019aide de protocoles fond\u00e9s sur des donn\u00e9es factuelles, ils pr\u00e9sentent des taux relativement faibles de complications, sont moins susceptibles d\u2019\u00eatre retir\u00e9s en raison de complications et prolongent la dur\u00e9e de vie des cath\u00e9ters<span class=\"s1\"><sup>2<\/sup><\/span>. Les ultrasons doivent \u00eatre utilis\u00e9s pour assurer que le cath\u00e9ter se trouve dans la veine appropri\u00e9e<span class=\"s1\"><sup>1,2<\/sup><\/span>.<\/p>\n<p class=\"p1\"><b>Un dispositif d\u2019acc\u00e8s intravasculaire ne convient pas \u00e0 tous les patients <\/b><\/p>\n<p class=\"p2\">Dans une \u00e9tude de sept ans portant sur 2\u00a0477\u00a0patients, Campagna et al ont constat\u00e9 que les PICC permettent d\u2019administrer des traitements en oncologie sans risque \u00e0 moyen ou \u00e0 long terme avec de faibles taux d\u2019infection et de thrombose<span class=\"s1\"><sup>5<\/sup><\/span>.<\/p>\n<p class=\"p2\">En cas de taux \u00e9lev\u00e9 de r\u00e9cidive, le professeur Mussa recommande de poser une CCI .<span class=\"s1\"><sup>1<\/sup><\/span> Si le risque de r\u00e9cidive est faible, l\u2019utilisation d\u2019un PICC pourrait \u00eatre plus adapt\u00e9e<span class=\"s1\"><sup>1<\/sup><\/span>. Les PICC en polyur\u00e9thane sont adapt\u00e9es pour les courtes dur\u00e9es (3 \u00e0 6\u00a0mois), mais si le patient n\u00e9cessite \u00e9galement une alimentation parent\u00e9rale pendant plus de 6\u00a0mois, un PICC valv\u00e9 en silicone constituerait un meilleur choix.<span class=\"s1\"><sup>1<\/sup><\/span>.<\/p>\n<p class=\"p1\">Le m\u00eame DAV ne doit pas \u00eatre utilis\u00e9 chez tous les patients<span class=\"s1\"><sup>1<\/sup><\/span>. Il est important de choisir le DAV appropri\u00e9 en fonction des besoins du patient<span class=\"s1\"><sup>6<\/sup><\/span>. Cette strat\u00e9gie permet de r\u00e9duire les co\u00fbts, att\u00e9nuer la douleur des patients et am\u00e9liorer la qualit\u00e9 du traitement<span class=\"s1\"><sup>1<\/sup><\/span>.<\/p>\n<p>&nbsp;<\/p>\n<div class=\"su-button-center\"><a href=\"https:\/\/lp.bd.com\/202004-MDS20-EU_EN-MACOVA-post_com-speakers_presentation-LP_LP-EN-01-MainLP.html\" class=\"su-button su-button-style-default\" style=\"color:#FFFFFF;background-color:#2D89EF;border-color:#246ec0;border-radius:5px\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"color:#FFFFFF;padding:0px 16px;font-size:13px;line-height:26px;border-color:#6cadf4;border-radius:5px;text-shadow:none\"> Regarder la vid\u00e9o<\/span><\/a><\/div>\n<p>&nbsp;<\/p>\n<div class=\"su-button-center\"><a href=\"https:\/\/lp.bd.com\/202004-MDS20-EU_EN-MACOVA-post_com-speakers_presentation-LP_LP-EN-01-MainLP.html\" class=\"su-button su-button-style-default\" style=\"color:#FFFFFF;background-color:#2D89EF;border-color:#246ec0;border-radius:5px\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"color:#FFFFFF;padding:0px 16px;font-size:13px;line-height:26px;border-color:#6cadf4;border-radius:5px;text-shadow:none\"> Regarder la presentation<\/span><\/a><\/div>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le choix du dispositif d\u2019abord vasculaire (DAV) est essentiel en oncologie. Les professionnels de l\u2019oncologie doivent tenir compte de plusieurs&#8230;<\/p>\n","protected":false},"author":2,"featured_media":1000,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[756],"tags":[1957,1959,1961,1963,1965,1657],"class_list":["post-999","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evenements-et-formation","tag-complication-fr","tag-cvc-fr","tag-implantedport-fr","tag-oncology-fr","tag-picc-fr","tag-vascularaccess-fr","speciality-abord-vasculaire","speciality-oncologie-medicale","speciality-securite-du-patient","speciality-soins-intensifs-soins-durgence","contenttype-article-fr","target-directeur-responsable-dhopital","target-medecin","target-soins-infirmiers"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PICC ou CCI, quel dispositif pour les patients atteints de cancer\u00a0? - BD IV News<\/title>\n<meta name=\"description\" content=\"The choice of vascular access device (VAD) is critical in oncology. Oncology professionals must consider multiple factors.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eu.bd.com\/iv-news\/fr\/evenements-et-formation\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PICC ou CCI, quel dispositif pour les patients atteints de cancer\u00a0? - BD IV News\" \/>\n<meta property=\"og:description\" content=\"The choice of vascular access device (VAD) is critical in oncology. Oncology professionals must consider multiple factors.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eu.bd.com\/iv-news\/fr\/evenements-et-formation\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"BD IV News\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-27T11:03:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-12-08T07:46:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2020\/07\/Onco-Choice_of_device-202007.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1138\" \/>\n\t<meta property=\"og:image:height\" content=\"804\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nina\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nina\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/evenements-et-formation\\\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/evenements-et-formation\\\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\\\/\"},\"author\":{\"name\":\"Nina\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#\\\/schema\\\/person\\\/59d9241f163013af9a439ffa23a0d44a\"},\"headline\":\"PICC ou CCI, quel dispositif pour les patients atteints de cancer\u00a0?\",\"datePublished\":\"2020-07-27T11:03:00+00:00\",\"dateModified\":\"2020-12-08T07:46:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/evenements-et-formation\\\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\\\/\"},\"wordCount\":686,\"publisher\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/evenements-et-formation\\\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/Onco-Choice_of_device-202007.jpg\",\"keywords\":[\"#complication\",\"#CVC\",\"#implantedport\",\"#oncology\",\"#PICC\",\"#vascularaccess\"],\"articleSection\":[\"\u00c9v\u00e9nements et formation\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/evenements-et-formation\\\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\\\/\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/evenements-et-formation\\\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\\\/\",\"name\":\"PICC ou CCI, quel dispositif pour les patients atteints de cancer\u00a0? - BD IV News\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/evenements-et-formation\\\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/evenements-et-formation\\\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/Onco-Choice_of_device-202007.jpg\",\"datePublished\":\"2020-07-27T11:03:00+00:00\",\"dateModified\":\"2020-12-08T07:46:25+00:00\",\"description\":\"The choice of vascular access device (VAD) is critical in oncology. Oncology professionals must consider multiple factors.\",\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/evenements-et-formation\\\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/fr\\\/evenements-et-formation\\\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/Onco-Choice_of_device-202007.jpg\",\"contentUrl\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/Onco-Choice_of_device-202007.jpg\",\"width\":1138,\"height\":804,\"caption\":\"Prof Baudolino Mussa speaking at MACOVA 2020\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#website\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/\",\"name\":\"BD IV News\",\"description\":\"Your source of information on intravenous therapy, medication delivery and vascular access management.\",\"publisher\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#organization\",\"name\":\"BD IV News\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/BD-Master-Logo-on-Warm-White-512X512px.png\",\"contentUrl\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/BD-Master-Logo-on-Warm-White-512X512px.png\",\"width\":512,\"height\":512,\"caption\":\"BD IV News\"},\"image\":{\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eu.bd.com\\\/iv-news\\\/#\\\/schema\\\/person\\\/59d9241f163013af9a439ffa23a0d44a\",\"name\":\"Nina\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7aa0c783d41a4a6797b60cd4ad873f4f56f4d1d7d5c4a7795789a531f0ca6e1f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7aa0c783d41a4a6797b60cd4ad873f4f56f4d1d7d5c4a7795789a531f0ca6e1f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7aa0c783d41a4a6797b60cd4ad873f4f56f4d1d7d5c4a7795789a531f0ca6e1f?s=96&d=mm&r=g\",\"caption\":\"Nina\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PICC ou CCI, quel dispositif pour les patients atteints de cancer\u00a0? - BD IV News","description":"The choice of vascular access device (VAD) is critical in oncology. Oncology professionals must consider multiple factors.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eu.bd.com\/iv-news\/fr\/evenements-et-formation\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\/","og_locale":"en_GB","og_type":"article","og_title":"PICC ou CCI, quel dispositif pour les patients atteints de cancer\u00a0? - BD IV News","og_description":"The choice of vascular access device (VAD) is critical in oncology. Oncology professionals must consider multiple factors.","og_url":"https:\/\/eu.bd.com\/iv-news\/fr\/evenements-et-formation\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\/","og_site_name":"BD IV News","article_published_time":"2020-07-27T11:03:00+00:00","article_modified_time":"2020-12-08T07:46:25+00:00","og_image":[{"width":1138,"height":804,"url":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2020\/07\/Onco-Choice_of_device-202007.jpg","type":"image\/jpeg"}],"author":"Nina","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Nina","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eu.bd.com\/iv-news\/fr\/evenements-et-formation\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\/#article","isPartOf":{"@id":"https:\/\/eu.bd.com\/iv-news\/fr\/evenements-et-formation\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\/"},"author":{"name":"Nina","@id":"https:\/\/eu.bd.com\/iv-news\/#\/schema\/person\/59d9241f163013af9a439ffa23a0d44a"},"headline":"PICC ou CCI, quel dispositif pour les patients atteints de cancer\u00a0?","datePublished":"2020-07-27T11:03:00+00:00","dateModified":"2020-12-08T07:46:25+00:00","mainEntityOfPage":{"@id":"https:\/\/eu.bd.com\/iv-news\/fr\/evenements-et-formation\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\/"},"wordCount":686,"publisher":{"@id":"https:\/\/eu.bd.com\/iv-news\/#organization"},"image":{"@id":"https:\/\/eu.bd.com\/iv-news\/fr\/evenements-et-formation\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2020\/07\/Onco-Choice_of_device-202007.jpg","keywords":["#complication","#CVC","#implantedport","#oncology","#PICC","#vascularaccess"],"articleSection":["\u00c9v\u00e9nements et formation"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/eu.bd.com\/iv-news\/fr\/evenements-et-formation\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\/","url":"https:\/\/eu.bd.com\/iv-news\/fr\/evenements-et-formation\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\/","name":"PICC ou CCI, quel dispositif pour les patients atteints de cancer\u00a0? - BD IV News","isPartOf":{"@id":"https:\/\/eu.bd.com\/iv-news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/eu.bd.com\/iv-news\/fr\/evenements-et-formation\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\/#primaryimage"},"image":{"@id":"https:\/\/eu.bd.com\/iv-news\/fr\/evenements-et-formation\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2020\/07\/Onco-Choice_of_device-202007.jpg","datePublished":"2020-07-27T11:03:00+00:00","dateModified":"2020-12-08T07:46:25+00:00","description":"The choice of vascular access device (VAD) is critical in oncology. Oncology professionals must consider multiple factors.","inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eu.bd.com\/iv-news\/fr\/evenements-et-formation\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/eu.bd.com\/iv-news\/fr\/evenements-et-formation\/picc-ou-cci-quel-dispositif-pour-les-patients-atteints-de-cancer\/#primaryimage","url":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2020\/07\/Onco-Choice_of_device-202007.jpg","contentUrl":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2020\/07\/Onco-Choice_of_device-202007.jpg","width":1138,"height":804,"caption":"Prof Baudolino Mussa speaking at MACOVA 2020"},{"@type":"WebSite","@id":"https:\/\/eu.bd.com\/iv-news\/#website","url":"https:\/\/eu.bd.com\/iv-news\/","name":"BD IV News","description":"Your source of information on intravenous therapy, medication delivery and vascular access management.","publisher":{"@id":"https:\/\/eu.bd.com\/iv-news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eu.bd.com\/iv-news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/eu.bd.com\/iv-news\/#organization","name":"BD IV News","url":"https:\/\/eu.bd.com\/iv-news\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/eu.bd.com\/iv-news\/#\/schema\/logo\/image\/","url":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2024\/04\/BD-Master-Logo-on-Warm-White-512X512px.png","contentUrl":"https:\/\/eu.bd.com\/iv-news\/wp-content\/uploads\/2024\/04\/BD-Master-Logo-on-Warm-White-512X512px.png","width":512,"height":512,"caption":"BD IV News"},"image":{"@id":"https:\/\/eu.bd.com\/iv-news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/eu.bd.com\/iv-news\/#\/schema\/person\/59d9241f163013af9a439ffa23a0d44a","name":"Nina","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/7aa0c783d41a4a6797b60cd4ad873f4f56f4d1d7d5c4a7795789a531f0ca6e1f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7aa0c783d41a4a6797b60cd4ad873f4f56f4d1d7d5c4a7795789a531f0ca6e1f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7aa0c783d41a4a6797b60cd4ad873f4f56f4d1d7d5c4a7795789a531f0ca6e1f?s=96&d=mm&r=g","caption":"Nina"}}]}},"lang":"fr","translations":{"fr":999},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/posts\/999","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/comments?post=999"}],"version-history":[{"count":2,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/posts\/999\/revisions"}],"predecessor-version":[{"id":1430,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/posts\/999\/revisions\/1430"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/media\/1000"}],"wp:attachment":[{"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/media?parent=999"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/categories?post=999"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eu.bd.com\/iv-news\/wp-json\/wp\/v2\/tags?post=999"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}